- This event has passed.
MoU between KAUST and Janssen Pharmaceutical Company of Johnson & Johnson
December 9 5:54 PM
KAUST is hosting this hybrid event to announce their partnership with Janssen Pharmaceutical Companies of Johnson & Johnson to create impact for the Kingdom of Saudi Arabia in line with Vision 2030 objectives. The MoU articulates opportunities for research and innovation engagement in the area of Neglected Tropical Disease, with a specific focus on Dengue, which includes the possibility of establishing an Innovative Centre for R&D in infectious disease in the National BioPark based at KAUST Research and Technology Park (KRTP).